Charley Grant

The FDA seems likely to approve an experimental gene therapy to treat a rare disease. That is translating to big gains for Sarepta Therapeutics shareholders. The biotech company’s shares were up nearly 30% in early trading Monday, after a panel of outside experts voted 8-to-6 to recommend approval

Amgen’s nearly $28 billion cash deal to buy Horizon Therapeutics is reportedly in jeopardy. That is translating to a rough morning for Horizon shareholders. Horizon shares are down nearly 17% in premarket trading Tuesday, after Bloomberg and Reuters reported that the Federal Trade Commission is pla

Catalent's financials are still past due, but investors are looking forward. The pharmaceuticals contract manufacturer said Friday it is unable to file its financial results with the SEC for the fiscal third quarter, which ended in March. That’s the second time the numbers have been delayed; Catale

Nvidia and other tech stocks have added billions of dollars in market value as the technology has boomed

Nvidia’s 24% rally in Thursday’s session turned heads on Wall Street and raised questions about whether the AI-driven market frenzy is becoming a bubble. But it wasn’t necessarily ret

The Nasdaq Composite extends winning streak to five weeks as tech stocks rally.

It’s shaping up to be an [ugly morning for retail stocks](https://www.wsj/articles/macys-earnings-m-q1-2023-b9f700c3). + **Dollar General** cut this fiscal year’s sales and profit outlook and said it would slow the pace of new store openings. Dollar General stock was recently down around 16.6%.

Analysts have raced to boost their price targets on the chip maker’s stock after the company’s market value gained $650 billion since October.

An investor craze for artificial intelligence has powered Nvidia’s dizzying rise and pushed the stock to lofty valuations. Wall Street analysts are predicting it has more room to run. [Nvidia](https://ww

Dish Network was the S&P 500's top performer shortly after trading began on Friday, after a report of Amazon's possible entry into the telecom business sent stocks spinning. That's a welcome change for shar